India to United States: Diphenhydramine Export Trade Route
India has recorded 470 verified shipments of Diphenhydramine exported to United States, representing a combined trade value of $16.0M USD. This corridor is served by 19 active Indian exporters, with an average shipment value of $34.0K USD. The leading Indian exporter is MICRO LABS LIMITED, which accounts for 31% of total export value with 34 shipments worth $5.0M USD. On the buying side, CARDINAL 3PL is the largest importer in United States with $5.5M USD in purchases. The top 3 suppliers — MICRO LABS LIMITED, ELYSIUM PHARMACEUTICALS LTD, GRANULES INDIA LIMITED — together control 65% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Diphenhydramine corridor is one of India's established pharmaceutical export routes, with 470 shipments documented worth a combined $16.0M USD. The route is dominated by MICRO LABS LIMITED, which alone accounts for roughly 31% of all export value, reflecting the consolidated nature of India's diphenhydramine manufacturing sector.
Across 19 active suppliers, the average shipment value stands at $34.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with diphenhydramine's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 21.6%, placing it at rank #15 among India's top diphenhydramine export destinations globally.
On the import side, key buyers of Indian diphenhydramine in United States include CARDINAL 3PL, SPIRIT PHARMACEUTICALS LLC, GRANULES CONSUMER HEALTH and 46 others. CARDINAL 3PL is the single largest importer with 36 shipments valued at $5.5M USD.
Route Characteristics
- Average transit34 days
- Peak seasonQ2
- Primary modeSea freight
- Top portMUNDRA SEA
Market Position
- Global rank#15
- Annual growth+21.6%
- Demand growth+20.2%
- Regulatory ease83/100
Top 10 Indian Diphenhydramine Exporters to United States
Showing top 10 of 19 Indian suppliers exporting Diphenhydramine to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MICRO LABS LIMITED Avg $145.7K per shipment | 34 | $5.0M | 31.0% |
| 2 | ELYSIUM PHARMACEUTICALS LTD Avg $36.0K per shipment | 95 | $3.4M | 21.4% |
| 3 | GRANULES INDIA LIMITED Avg $31.3K per shipment | 65 | $2.0M | 12.7% |
| 4 | ELYSIUM PHARMACEUTICALS LIMITED Avg $42.2K per shipment | 38 | $1.6M | 10.0% |
| 5 | TRUECARE BIOMEDIX Avg $15.9K per shipment | 93 | $1.5M | 9.2% |
| 6 | TRUE CARE BIOMEDIX Avg $47.3K per shipment | 15 | $709.8K | 4.4% |
| 7 | MICRO LABS LTD Avg $270.3K per shipment | 2 | $540.7K | 3.4% |
| 8 | SOFTGEL HEALTHCARE PRIVATE LIMITED Avg $14.0K per shipment | 21 | $293.8K | 1.8% |
| 9 | GLAND PHARMA LTD Avg $119.4K per shipment | 2 | $238.7K | 1.5% |
| 10 | ALDER BIOCHEM PRIVATE LIMITED Avg $9.8K per shipment | 19 | $185.4K | 1.2% |
This table shows the top 10 of 19 Indian companies exporting diphenhydramine to United States, ranked by total trade value. The listed exporters are: MICRO LABS LIMITED, ELYSIUM PHARMACEUTICALS LTD, GRANULES INDIA LIMITED, ELYSIUM PHARMACEUTICALS LIMITED, TRUECARE BIOMEDIX, TRUE CARE BIOMEDIX, MICRO LABS LTD, SOFTGEL HEALTHCARE PRIVATE LIMITED, GLAND PHARMA LTD, ALDER BIOCHEM PRIVATE LIMITED. MICRO LABS LIMITED is the dominant supplier with 34 shipments worth $5.0M USD, giving it a 31% market share. The top 3 suppliers together account for 65% of the total trade value on this route.
Showing top 10 of 19 total Indian exporters on the India to United States Diphenhydramine export route.
Top 10 Diphenhydramine Importers in United States
Showing top 10 of 49 known buyers in United States receiving Diphenhydramine shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian diphenhydramine in United States include CARDINAL 3PL, SPIRIT PHARMACEUTICALS LLC, GRANULES CONSUMER HEALTH, STRIVE PHARMACEUTICALS, PL DEVELOPMENTS, among 49 total buyers. The largest importer is CARDINAL 3PL, accounting for $5.5M USD across 36 shipments — representing 34% of all diphenhydramine imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CARDINAL 3PL | 36 | $5.5M | 34.3% |
| 2 | SPIRIT PHARMACEUTICALS LLC | 80 | $3.2M | 19.9% |
| 3 | GRANULES CONSUMER HEALTH | 56 | $1.4M | 9.0% |
| 4 | STRIVE PHARMACEUTICALS | 60 | $1.1M | 6.9% |
| 5 | PL DEVELOPMENTS | 34 | $854.3K | 5.3% |
| 6 | GRANULES USA INC | 6 | $497.0K | 3.1% |
| 7 | SPIRIT PHARMACEUTICALS LLC, | 8 | $471.5K | 2.9% |
| 8 | PRODOSE INC. | 6 | $366.3K | 2.3% |
| 9 | SHREE HARI INTERNATIONAL LLC | 15 | $333.0K | 2.1% |
| 10 | EVERSANA LIFE SCIENCE SERVICES LLC | 2 | $238.7K | 1.5% |
Showing top 10 of 49 Diphenhydramine importers in United States on this route.
Top 10 Diphenhydramine Formulations Imported by United States
Showing top 10 of 291 product formulations shipped on the India to United States Diphenhydramine route, ranked by trade value
United States imports a wide range of diphenhydramine formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — ACETAMINOPHEN & DIPHENHYDRAMINE HCL TABL — accounts for $476.3K USD across 7 shipments. There are 291 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ACETAMINOPHEN & DIPHENHYDRAMINE HCL TABL | 7 | $476.3K | 3.0% |
| 2 | DIPHENHYDRAMINE HCL INJECTION USP 50mg/ml 25X1ML QTY- 31436.000 | 1 | $396.1K | 2.5% |
| 3 | DIPHENHYDRAMINE HYDROCHLORIDE INJECTIONUSP 50MG/ML (25X1ML) - TAX INVOICE NO: 714201047 DT: 29.04.2024 | 3 | $392.3K | 2.5% |
| 4 | DIPHENHYDRAMINE HCL INJECTION USP 50mg/ml 25X1ML QTY- 31203.000 | 1 | $385.0K | 2.4% |
| 5 | DIPHENHYDRAMINE HCL INJECTION USP 50MG/ML ( 25X1ML ) ( QTY- 31080.000 ) | 1 | $383.5K | 2.4% |
| 6 | DIPHENHYDRAMINE HCL INJECTION USP 50MG/ML ( 25X1ML ) ( QTY- 25294.000 )PCS | 3 | $310.9K | 1.9% |
| 7 | DIPHENHYDRAMINE HCL INJECTION USP 50mg/m | 2 | $305.8K | 1.9% |
| 8 | DIPHENHYDRAMINE HCL 25MG TABLETS S-4 (PINK) (ANNEXURE-B) AS PER INVOICETBS | 9 | $295.3K | 1.8% |
| 9 | DIPHENHYDRAMINE HCL INJECTION USP 50mg/m | 3 | $289.2K | 1.8% |
| 10 | DIPHENHYDRAMINE HCL 25MG TABLETS S-4 (PINK) (ANNEXURE-B) AS PER INVTBS | 6 | $248.7K | 1.6% |
Showing top 10 of 291 Diphenhydramine formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 80%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
MUNDRA SEA handles the highest volume with 121 shipments. Transit time averages 34 days by sea.
Market Dynamics
India's diphenhydramine exports to United States are driven primarily by a handful of large-scale manufacturers. MICRO LABS LIMITED with 34 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 19 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — MICRO LABS LIMITED, ELYSIUM PHARMACEUTICALS LTD, GRANULES INDIA LIMITED — together account for 65% of total trade value on this route. The average shipment value of $34.0K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as diphenhydramine hcl injection usp 50mg/ml 25x1ml qty- 31436.000 and diphenhydramine hydrochloride injectionusp 50mg/ml (25x1ml) - tax invoice no: 714201047 dt: 29.04.2024, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, CARDINAL 3PL is the largest importer with 36 shipments worth $5.5M USD — representing 34% of all diphenhydramine imports from India on this route. A total of 49 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $16.0M
- Avg. Shipment
- $34.0K
- Suppliers
- 19
- Buyers
- 49
- Transit (Sea)
- ~34 days
- Annual Growth
- +21.6%
Related Analysis
Reverse Direction
United States → India — Diphenhydramine (Import)Other Diphenhydramine Routes
Unlock the Full India to United States Diphenhydramine Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 470 shipments on this route.
Frequently Asked Questions — India to United States Diphenhydramine Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Diphenhydramine to United States?
The leading Indian exporters of Diphenhydramine to United States are MICRO LABS LIMITED, ELYSIUM PHARMACEUTICALS LTD, GRANULES INDIA LIMITED. MICRO LABS LIMITED holds the largest market share at approximately 31% of total trade value on this route.
Q What is the total value of Diphenhydramine exports from India to United States?
India exports Diphenhydramine to United States worth approximately $16.0M USD across 470 recorded shipments. The average value per shipment is $34.0K USD.
Q Which ports does India use to ship Diphenhydramine to United States?
The most active port of origin is MUNDRA SEA with 121 shipments. Indian exporters primarily use sea freight for this route, with 80% of shipments going by sea and 26% by air.
Q How long does shipping take from India to United States for Diphenhydramine?
The average transit time for Diphenhydramine shipments from India to United States is approximately 34 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to United States Diphenhydramine trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 21.6% with demand growth tracking at 20.2%. The route is ranked #15 among India's top Diphenhydramine export destinations globally.
Q How many suppliers are active on the India to United States Diphenhydramine route?
There are currently 19 active Indian suppliers exporting Diphenhydramine to United States. The market is moderately concentrated with MICRO LABS LIMITED accounting for 31% of total shipment value.
Q Who are the main importers of Diphenhydramine from India in United States?
The leading importers of Indian Diphenhydramine in United States include CARDINAL 3PL, SPIRIT PHARMACEUTICALS LLC, GRANULES CONSUMER HEALTH, STRIVE PHARMACEUTICALS, PL DEVELOPMENTS. CARDINAL 3PL is the largest buyer with 36 shipments worth $5.5M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Diphenhydramine.
- 2.Supplier/Buyer Matching: 19 Indian exporters and 49 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 470 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
470 Verified Shipments
19 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists